FDA Official Warns of Vaccine Challenges Under Trump Administration

Peter Marks emphasizes the need for open dialogue on vaccine safety as RFK Jr. is nominated to lead Health and Human Services.

Peter Marks, head of the FDA's Center for Biologics Evaluation and Research, predicts increased scrutiny of vaccine development and safety under the incoming Trump administration.
President-elect Donald Trump has nominated vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services, raising concerns among public health officials and vaccine advocates.
Marks views the nomination as an opportunity to educate the public on the life-saving benefits of vaccines but warns of severe consequences if vaccination rates decline significantly.
Public health experts fear a resurgence of preventable diseases like measles and polio if vaccine hesitancy grows due to misinformation and skepticism.
Marks calls for transparent communication and a fact-based approach to counter vaccine misinformation, while expressing hope for moderation in upcoming vaccine debates.